GYNORYLAQ™-VLINIVAL™: Ψ-Guided Personalized Neoantigen Peptide Vaccine for High-Risk Endometrial Cancer

Name: GYNORYLAQ™-VLINIVAL™: Ψ-Guided Personalized Neoantigen Peptide Vaccine for High-Risk Endometrial Cancer
License: Public Domain

Biogenea Pharmaceuticals Ltd.

ClinicalTrials.gov · Datasets · License: Public Domain

endometrial carcinoma, endometrial carcinoma stage iii

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 261333
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.